EP3867251
KRAS G12C INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.10.2019EP published:
7.9.2022EP application number:
19791429.4
EPO information:
European Patent Register
Max expiry date:
7.10.2039
Title in English:
KRAS G12C INHIBITORSLanguage of the patent:
English
Timeline
Today
8.10.2019EP application
7.9.2022EP Publication
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
BARDA, David AnthonyAddress:
Indianapolis, Indiana 46206-6288, US
Name:
COATES, David AndrewAddress:
Indianapolis, Indiana 46206-6288, US
Name:
LINDER, Ryan JamesAddress:
Indianapolis, Indiana 46206-6288, US
Name:
PENG, Sheng-BinAddress:
Indianapolis, Indiana 46206-6288, US
Name:
ZIA-EBRAHIMI, Mohammad SadeghAddress:
Indianapolis, Indiana 46206-2688, US
Priority
Number:
201862745502 PDate:
15.10.2018Country:
US
Classification
Categories:
C07D 417/14, A61P 35/00, A61K 31/517